Skip to main content
. 2017 Apr 21;8(24):39198–39208. doi: 10.18632/oncotarget.17338

Table 5. Stratified analyses between PD-1 rs10204525 T>C polymorphism and EGJA risk by sex, age, smoking status and alcohol consumption.

Variable PD-1 rs10204525 T>C (case/control) a Adjusted OR b (95% CI); P
TT TC CC TT TC CC TC / CC CC vs. (TC/TT)
Sex
Male 384/621 289/476 71/94 1.00 0.96 (0.79–1.17);
P: 0.704
1.20 (0.86–1.67);
P: 0.294
1.04 (0.86–1.25);
P: 0.700
1.24(0.90–1.72);
P: 0.194
Female 160/249 108/196 27/38 1.00 0.79(0.58–1.08);
P: 0.140
1.08 (0.63–1.85);
P: 0.776
0.89(0.66–1.19);
P: 0.422
1.23 (0.73–2.08);
P: 0.433
Age
<64 245/442 187/310 50/71 1.00 1.04 (0.82–1.33);
P: 0.725
1.26 (0.85–1.87);
P: 0.260
1.13(0.90–1.42);
P: 0.283
1.27 (0.86–1.86);
P: 0.226
≥64 299/428 210/362 48/61 1.00 0.80 (0.64–1.01);
P: 0.055
1.10 (0.73–1.66);
P: 0.640
0.88 (0.71–1.09);
P: 0.237
1.24 (0.83–1.84);
P: 0.291
Smoking status
Never 385/679 300/534 68/108 1.00 0.94(0.78–1.13);
P: 0.505
1.08(0.78–1.50);
P: 0.644
1.01 (0.84–1.21);
P: 0.926
1.14 (0.83–1.57);
P: 0.419
Ever 159/191 97/138 30/24 1.00 0.84 (0.60–1.18);
P: 0.321
1.60 (0.89–2.88);
P: 0.115
0.97 (0.71–1.33);
P: 0.849
1.74 (0.98–3.08);
P: 0.058
Alcohol consumption
Never 464/774 339/610 83/121 1.00 0.89(0.74–1.05);
P: 0.171
1.11 (0.82–1.50);
P: 0.508
0.96 (0.82–1.14);
P: 0.660
1.20(0.89–1.61);
P: 0.230
Ever 80/96 58/62 15/11 1.00 1.11 (0.68–1.79);
P: 0.680
2.22(0.91–5.43);
P: 0.080
1.26 (0.80–1.99);
P: 0.328
2.14 (0.89–5.10);
P: 0.088

aThe genotyping was successful in 1063 (97.74%) EGJA cases, and 1677 (99.82%) controls for PD-1 rs10204525 T>C;

bAdjusted for age, sex, smoking status and alcohol consumption (besides stratified factors accordingly) in a logistic regression model.